Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure.
Christine G LeeAdam CiarleglioSharon L EdelsteinJill P CrandallDana DabeleaRonald B GoldbergSteven E KahnWilliam C KnowlerMaxwell T MaNeil H WhiteWilliam H Hermannull nullPublished in: Diabetes care (2024)
The likelihood of DSPN was similar across DPP treatment groups but higher for those with diabetes, longer diabetes duration, and higher cumulative glycemic exposure. ILS may have long-term benefits on DSPN for older adults.